These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28387202)

  • 1. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.
    Cheung BM; Cheng CH; Lau CP; Wong CK; Ma RC; Chu DW; Ho DH; Lee KL; Tse HF; Wong AS; Yan BP; Yan VW
    Hong Kong Med J; 2017 Apr; 23(2):191-201. PubMed ID: 28387202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.
    Zarnke KB; McAlister FA; Campbell NR; Levine M; Schiffrin EL; Grover S; McKay DW; Myers MG; Wilson TW; Rabkin SW; Feldman RD; Burgess E; Bolli P; Honos G; Lebel M; Mann K; Abbott C; Tobe S; Petrella R; Touyz RM;
    Can J Cardiol; 2002 Jun; 18(6):604-24. PubMed ID: 12107419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus statement on ischaemic stroke care in Hong Kong.
    Ng PW; Huang CY; Cheung RT; Wong KS; Wong CK; Lam JM; ;
    Hong Kong Med J; 2004 Apr; 10(2):124-9. PubMed ID: 15075433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Cléroux J; Feldman RD; Petrella RJ
    CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension.
    Chan KK; Szeto CC; Lum CCM; Ng PW; Kong APS; Lau KP; Leung JYY; Lui SL; Mo KL; Mok FCK; Mok VCT; Yan BPY; Li PKT
    Hong Kong Med J; 2020 Oct; 26(5):432-437. PubMed ID: 33089788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):913-9. PubMed ID: 25443815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between dietary habits and risk factors for cardiovascular diseases in a Hong Kong Chinese working population--the "Better Health for Better Hong Kong" (BHBHK) health promotion campaign.
    Ko GT; Chan JC; Tong SD; Chan AW; Wong PT; Hui SS; Kwok R; Chan CL
    Asia Pac J Clin Nutr; 2007; 16(4):757-65. PubMed ID: 18042539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement.
    Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ;
    Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements.
    Wu JC; Chan AO; Chan YW; Cheung GC; Cheung TK; Kwan AC; Leung VK; Mak AD; Sze WC; Wong R
    Hong Kong Med J; 2017 Dec; 23(6):641-7. PubMed ID: 29226832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising atherothrombosis in Hong Kong: results of the Hong Kong data from a global atherothrombosis epidemiological survey.
    Tsang MW; Chu CL; Kam YW; Kwong KH; Lam CK; Ngan SY; Yu YK
    Hong Kong Med J; 2005 Feb; 11(1):36-41. PubMed ID: 15687514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten-year cardiovascular risk in a Hong Kong population.
    Chan WK; Chiu A; Ko GT; Wu MF; Liu FL; Choi KW
    J Cardiovasc Risk; 1999 Jun; 6(3):163-9. PubMed ID: 10463143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings-review of evidence on the definition of high blood pressure and goal of therapy.
    Lim MK; Ha SCN; Luk KH; Yip WK; Tsang CSH; Wong MCS
    Hong Kong Med J; 2019 Feb; 25(1):64-7. PubMed ID: 30648830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients.
    Chua GT; Li PH; Ho MH; Lai E; Ngai V; Yau FY; Kwan MY; Leung TF; Lee TH
    Hong Kong Med J; 2018 Oct; 24(5):527-531. PubMed ID: 30318478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.